Developer docs
API playgroundTry for free, no card

Search company profiles

Abela Pharm

Full company profile

uuid00qndf7

Namestring
Abela Pharm
Legal namestring
Abela Pharm d.o.o.
Websiteurl
abelapharm.rs
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Abela Pharm d.o.o. is a Serbian pharmaceutical company headquartered in Belgrade that researches, develops, manufactures, and markets natural dietary supplements, medical devices, and pharmaceutical products, with a core specialization in probiotics. The company's portfolio spans eleven therapeutic categories including gastroenterology (Bulardi, BebiCol Forte, EnteroBiotik, Flobian), pulmonology (PropoMucil), cardiology (ARTEROprotect, CardioVitamin), bone health (K2D3 VIVA), allergy (Immuno GD-Poly), urinary tract health (Naturoplex), men's health (Afrička Šljiva), and weight management (Herbafast), plus the prescription proton pump inhibitor Rabezol. The underlying technology platform centers on proprietary probiotic strain R&D — anchored by the 1,600 m2 Probiotic Excellence Center research facility — and the @TECH packaging system, a multi-layer laminate sachet with inert gas filling that guarantees probiotic cell count at end of shelf life rather than only at production. The company operates three GMP-certified manufacturing facilities in Serbia (Belgrade producing 7M+ packages annually, Stari Banovci, and Barice with 20M pharmaceutical unit capacity annually, the latter two acquired from STADA and Alvogen in 2019).

The business model is consumer health-focused, selling primarily through pharmacy distribution networks across Serbia and export markets spanning 19+ countries in Europe, the Middle East, North Africa, and Southeast Asia (Singapore entry realized March 2025), reaching an addressable population of over 400 million people. Go-to-market is sales-led and built around engagement with healthcare professionals — pediatricians, gastroenterologists, and pharmacists — through annual scientific symposiums (300-500+ attendees), CME-accredited training sessions, peer-reviewed publications (20+ clinical studies), and educational content via the Probiotic Excellence Center. Pricing is not publicly disclosed; products are positioned as premium, scientifically-backed natural supplements and pharmaceuticals differentiated by clinical evidence, packaging innovation, and European GMP certification enabling cross-border distribution. The company is privately held, led by General Director Davor J. Korčok (11+ years) with Scientific Director Krešimir Gjuračić overseeing probiotic research.

Short descriptiontext

Abela Pharm is a Serbian pharmaceutical company that researches, manufactures, and markets natural dietary supplements, probiotics, and pharmaceutical products across gastroenterology, cardiology, allergy, and related therapeutic areas, distributing through pharmacy networks in 19+ countries and serving healthcare professionals and consumers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBelgrade
HQ citystring
Belgrade
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
probiotic supplements, dietary supplements, pharmaceutical manufacturing, natural health products, medical devices
Industry3 codes
PRIMARYCRADAGAC
Multivitamins & Daily Packs
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYCRAOAHAB
OTC Medicines & Consumer Health Products Distribution
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code3 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Dietary Supplements and Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Dietary Supplements
TypeOne Time License
Description

Production and sale of natural dietary supplements including probiotics (Bulardi, Bebicol, Probiotik EnteroBiotik), vitamins and minerals (BiVits ACTIVA), weight management (Herbafast), and other health products sold through pharmacy networks.

abelapharm.rs
2Pharmaceutical Products
TypeOne Time License
Description

Following acquisition of GMP-certified manufacturing facilities from STADA and Alvogen, the company expanded into production of pharmaceutical drugs including Rabezol (proton pump inhibitor) and other medicinal products.

abelapharm.rs
3Medical Devices
TypeOne Time License
Description

Production of medical devices including probiotic preparations and related healthcare products.

abelapharm.rs
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1Herbafast
Description

Product line for weight management with 18 years of experience, includes Herbafast Lady, Herbafast Gentleman, Herbafast Fiber, Herbafast Detox, and Herbafast Avantgarde Mineral Biotic

abelapharm.rs
+10 more records
Core offering1 text field

AbelaPharm develops, manufactures, and markets natural dietary supplements, probiotics, vitamins, herbal preparations, medical devices, and pharmaceutical drugs across 11 therapeutic categories. The company operates three GMP-certified production facilities in Serbia and sells its branded products through pharmacy chains domestically and through local distributors in 19+ export countries reaching more than 400 million consumers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Guaranteed probiotic cell count at end of shelf life (not just at production), unlike products that only declare counts at manufacturing
+5 more records
Product overview1 text field

AbelaPharm is a Serbian pharmaceutical company focused on research, development, and manufacturing of completely natural dietary supplements, medical devices, and pharmaceutical products. The portfolio is organized across 11 therapeutic categories: Pulmonology/ORL (PropoMucil), Gastroenterology (Bulardi, BebiCol Forte, Bebicol, EnteroBiotik, Flobian), Bones/Joints/Muscles (Tensilen, K2D3 VIVA), Cardiology (ARTEROprotect, CardioVitamin), Vitamins & Minerals (BiVits ACTIVA), Mood (single product), Dermatology, Urinary Tract (Naturoplex, Naturoplex Brusnica), Allergy (Immuno GD-Poly), Men's Health (Afrička Šljiva, Afrička Šljiva FORTE, Kapi Afričke Šljive), and Weight Management (Herbafast Lady, Herbafast Fiber, Herbafast Detox, Herbafast Avantgarde). The company also manufactures the proton pump inhibitor drug Rabezol and operates the Probiotic Excellence Center for scientific research and education. The proprietary @TECH packaging technology is a key innovation ensuring probiotic stability. Products are exported to 19 countries, reaching over 400 million people in the EU, Middle East, America, and Africa.

Product and service2 records
1Bulardi
CategoryProbiotic dietary supplements
Description

Flagship probiotic supplement containing Saccharomyces boulardii, available in multiple formulations (capsules, junior, Flobian). Used for prevention and treatment of antibiotic-associated diarrhea, traveler's diarrhea, and other digestive conditions. The probiotic yeast can be taken simultaneously with antibiotics.

2BebiCol Forte
Scale indicator18 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
1ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Probiotic Excellence Center partners with ESPGHAN for scientific exchange and education. ESPPGHAN presidents and leading experts participate in AbelaPharm-organized symposiums, presenting latest guidelines on probiotic use in children.

abelapharm.rs
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

EAGEN marked 53 years of activity with a symposium in Belgrade organized with Probiotic Excellence Center as partner. Five EAGEN presidents participated, presenting latest European guidelines for digestive disease treatment.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-01-01
Description

Biotechnological company with which Probiotic Excellence Center researchers examined the resistance of Lactobacillus plantarum strains to acidic environment and stress caused by high pH values.

4University of Belgrade Faculty of Pharmacy
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

AbelaPharm is a scientific-teaching base for pharmacy and technology students. PhD, specialist, and graduate theses have been developed at the Probiotic Excellence Center. Students present research at international congresses.

abelapharm.rs
5Medical Faculty Kragujevac
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Probiotic Excellence Center opened for pharmacy students from the Medical Faculty in Kragujevac, providing practical knowledge in probiotic production, research, and quality control. Partnership with Faculty Dean Prof. Dr Vladimir Jakovljević.

abelapharm.rs
6Savez medicinskih sestara predškolskih ustanova Srbije (Union of Medical Nurses of Preschool Institutions of Serbia)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Collaboration on educational programs for parents and kindergarten staff on gut flora, immunity, and preventive health. Jointly published 'Guide for Preschool Age' and allergy guides through a 3-year educational workshop program.

abelapharm.rs
7Udruženje Treće doba (Third Age Association)
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2023-01-01
Description

Partnership for World Osteoporosis Day event where AbelaPharm organized bone density screenings for elderly members of the association.

abelapharm.rs
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2023-01-01
Description

AbelaPharm participated in the 9th Pro-femina conference organized for World Menopause Day, with a panel on osteoporosis prevention.

9Harvard Medical Community
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Probiotic Excellence Center references Harvard research on gut microbiota and leaky gut syndrome. Scientific director Dr. Krešimir Gjuračić maintains connections with leading international researchers in the probiotic field.

abelapharm.rs
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Probiotic Excellence Center conducted the 'Probiotics from Industry to Digestive Tract' project at the Medical Faculty in Niš, enhancing knowledge and competencies of future professionals.

11Fondacija Nataša Kovačević
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2021-01-01
Description

Charitable partnership for the 'Take Health Into Your Own Hands, Let All Children Jump' campaign providing dynamic prosthetics for children. AbelaPharm donated 1,447,860 dinars — 1 RSD per box of BiVits ACTIVA sold between Dec 2021 and April 2022.

abelapharm.rs
Strategic tierCoreTypeOthersAnnounced on2019-01-01
Description

AbelaPharm acquired a pharmaceutical manufacturing factory in Stari Banovci from German STADA Group in April 2019 for over 4 million euros. This represents a strategic acquisition enabling pharmaceutical drug manufacturing alongside dietary supplements.

Strategic tierCoreTypeOthersAnnounced on2019-01-01
Description

AbelaPharm acquired a pharmaceutical manufacturing facility in Barice, near Vršac, from American company Alvogen. The modern GMP-certified facility was built in 2011 and provides capacity for 20 million pharmaceutical units per year.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers9 records
TypeBroad incumbent
Description

German generics and consumer health company from which AbelaPharm acquired its Stari Banovci factory in 2019. Comparable as a European-focused generics and OTC manufacturer operating in the same regulatory and channel environment AbelaPharm is now targeting.

TypeBroad incumbent
Description

Global bioscience company (now Novonesis post-merger with Novozymes) supplying probiotic strains, cultures, and enzymes to dietary supplement and dairy customers worldwide. Comparable as a science-backed probiotic supplier, though primarily B2B and far larger.

3BioGaia
TypeDirect peer
Description

Swedish probiotic R&D and marketing company specializing in Lactobacillus reuteri strains, sold globally through pharmacy and consumer health channels. Most directly comparable peer given probiotic focus, similar pharmacy-led distribution, and clinical evidence-driven positioning.

4Winclove Probiotics
TypeDirect peer
Description

Dutch probiotic manufacturer focused on multi-strain and indication-specific formulations sold through pharmacies and healthcare professionals in Europe. Comparable in clinical evidence emphasis, pharmacy distribution, and indication-specific positioning (e.g., pediatric, GI).

TypeBroad incumbent
Description

US-headquartered generics and pharmaceutical manufacturer whose Barice factory AbelaPharm acquired in 2019. Comparable as a generics and OTC player with European manufacturing footprint and a customer overlap with AbelaPharm's pharmaceutical ambitions.

6Lallemand Health Solutions
TypeDirect peer
Description

Canadian probiotic manufacturer producing Saccharomyces boulardii (the same yeast that anchors AbelaPharm's flagship Bulardi product) and other microbial solutions for human health. Closest direct competitor in the S. boulardii space and a benchmark for probiotic contract manufacturing.

TypeBroad incumbent
Description

Global probiotic beverage and supplement giant with Lactobacillus casei strain products distributed in 40+ countries. Comparable as a category-defining incumbent in probiotics, though much larger and brand-led versus AbelaPharm's science-led pharmacy positioning.

TypeDirect peer
Description

Swedish probiotic company developing and commercializing probiotic strains (including Lactobacillus plantarum 299v, the same strain used in AbelaPharm's Flobian). Direct competitor in documented probiotic strains and B2B/B2C probiotic commercialization.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Abela Pharm

Dietary Supplements and Pharmaceutical Manufacturingabelapharm.rs

Abela Pharm is a Serbian pharmaceutical company that researches, manufactures, and markets natural dietary supplements, probiotics, and pharmaceutical products across gastroenterology, cardiology, allergy, and related therapeutic areas, distributing through pharmacy networks in 19+ countries and serving healthcare professionals and consumers globally.

What Abela Pharm does

Abela Pharm d.o.o. is a Serbian pharmaceutical company headquartered in Belgrade that researches, develops, manufactures, and markets natural dietary supplements, medical devices, and pharmaceutical products, with a core specialization in probiotics. The company's portfolio spans eleven therapeutic categories including gastroenterology (Bulardi, BebiCol Forte, EnteroBiotik, Flobian), pulmonology (PropoMucil), cardiology (ARTEROprotect, CardioVitamin), bone health (K2D3 VIVA), allergy (Immuno GD-Poly), urinary tract health (Naturoplex), men's health (Afrička Šljiva), and weight management (Herbafast), plus the prescription proton pump inhibitor Rabezol. The underlying technology platform centers on proprietary probiotic strain R&D — anchored by the 1,600 m2 Probiotic Excellence Center research facility — and the @TECH packaging system, a multi-layer laminate sachet with inert gas filling that guarantees probiotic cell count at end of shelf life rather than only at production. The company operates three GMP-certified manufacturing facilities in Serbia (Belgrade producing 7M+ packages annually, Stari Banovci, and Barice with 20M pharmaceutical unit capacity annually, the latter two acquired from STADA and Alvogen in 2019).

The business model is consumer health-focused, selling primarily through pharmacy distribution networks across Serbia and export markets spanning 19+ countries in Europe, the Middle East, North Africa, and Southeast Asia (Singapore entry realized March 2025), reaching an addressable population of over 400 million people. Go-to-market is sales-led and built around engagement with healthcare professionals — pediatricians, gastroenterologists, and pharmacists — through annual scientific symposiums (300-500+ attendees), CME-accredited training sessions, peer-reviewed publications (20+ clinical studies), and educational content via the Probiotic Excellence Center. Pricing is not publicly disclosed; products are positioned as premium, scientifically-backed natural supplements and pharmaceuticals differentiated by clinical evidence, packaging innovation, and European GMP certification enabling cross-border distribution. The company is privately held, led by General Director Davor J. Korčok (11+ years) with Scientific Director Krešimir Gjuračić overseeing probiotic research.

Abela Pharm firmographics

Firmographics
Name
Abela Pharm
Legal name
Abela Pharm d.o.o.
Website
https://abelapharm.rs
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
51–100 employees
Short description
Abela Pharm is a Serbian pharmaceutical company that researches, manufactures, and markets natural dietary supplements, probiotics, and pharmaceutical products across gastroenterology, cardiology, allergy, and related therapeutic areas, distributing through pharmacy networks in 19+ countries and serving healthcare professionals and consumers globally.
Ownership category
akta.pro rank

Abela Pharm industry classification

Industry
Product category
Dietary Supplements and Pharmaceutical Manufacturing
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRADAGAC
Multivitamins & Daily Packs
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYCRAOAHAB
OTC Medicines & Consumer Health Products Distribution

Keywords

  • Probiotic supplements
  • Dietary supplements
  • Pharmaceutical manufacturing
  • Natural health products
  • Medical devices

Where Abela Pharm is headquartered

Location

Headquarters

HQ city
Belgrade

Offices4 records

Markets served

Abela Pharm business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Dietary Supplements: Production and sale of natural dietary supplements including probiotics (Bulardi, Bebicol, Probiotik EnteroBiotik), vitamins and minerals (BiVits ACTIVA), weight management (Herbafast), and other health products sold through pharmacy networks.
  2. Pharmaceutical Products: Following acquisition of GMP-certified manufacturing facilities from STADA and Alvogen, the company expanded into production of pharmaceutical drugs including Rabezol (proton pump inhibitor) and other medicinal products.
  3. Medical Devices: Production of medical devices including probiotic preparations and related healthcare products.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Abela Pharm product offering

Product offering

Core offering

AbelaPharm develops, manufactures, and markets natural dietary supplements, probiotics, vitamins, herbal preparations, medical devices, and pharmaceutical drugs across 11 therapeutic categories. The company operates three GMP-certified production facilities in Serbia and sells its branded products through pharmacy chains domestically and through local distributors in 19+ export countries reaching more than 400 million consumers.

Product overview

AbelaPharm is a Serbian pharmaceutical company focused on research, development, and manufacturing of completely natural dietary supplements, medical devices, and pharmaceutical products. The portfolio is organized across 11 therapeutic categories: Pulmonology/ORL (PropoMucil), Gastroenterology (Bulardi, BebiCol Forte, Bebicol, EnteroBiotik, Flobian), Bones/Joints/Muscles (Tensilen, K2D3 VIVA), Cardiology (ARTEROprotect, CardioVitamin), Vitamins & Minerals (BiVits ACTIVA), Mood (single product), Dermatology, Urinary Tract (Naturoplex, Naturoplex Brusnica), Allergy (Immuno GD-Poly), Men's Health (Afrička Šljiva, Afrička Šljiva FORTE, Kapi Afričke Šljive), and Weight Management (Herbafast Lady, Herbafast Fiber, Herbafast Detox, Herbafast Avantgarde). The company also manufactures the proton pump inhibitor drug Rabezol and operates the Probiotic Excellence Center for scientific research and education. The proprietary @TECH packaging technology is a key innovation ensuring probiotic stability. Products are exported to 19 countries, reaching over 400 million people in the EU, Middle East, America, and Africa.

Differentiator

Problem solved

Functional benefit

Brands

  • Herbafast: Product line for weight management with 18 years of experience, includes Herbafast Lady, Herbafast Gentleman, Herbafast Fiber, Herbafast Detox, and Herbafast Avantgarde Mineral Biotic
  • Bulardi
  • PropoMucil
  • Naturoplex
  • Probiotic Excellence Center
  • Afrička Šljiva
  • Immuno GD-Poly
  • BiVits
  • Flobian
  • Probiotik EnteroBiotik
  • Rabezol

Products and services

  • Bulardi Flagship probiotic supplement containing Saccharomyces boulardii, available in multiple formulations (capsules, junior, Flobian). Used for prevention and treatment of antibiotic-associated diarrhea, traveler's diarrhea, and other digestive conditions. The probiotic yeast can be taken simultaneously with antibiotics.
  • BebiCol Forte

Quantifiable outcome

  • Guaranteed probiotic cell count at end of shelf life (not just at production), unlike products that only declare counts at manufacturing
  • +5 more outcomes

Companies that use Abela Pharm

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Abela Pharm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Abela Pharm partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition)coreStrategic or Co-development Partner · 1 January 2023Probiotic Excellence Center partners with ESPGHAN for scientific exchange and education. ESPPGHAN presidents and leading experts participate in AbelaPharm-organized symposiums, presenting latest guidelines on probiotic use in children.
  • EAGEN (European Association for Gastroenterology, Endoscopy and Nutrition)coreStrategic or Co-development Partner · 1 January 2023EAGEN marked 53 years of activity with a symposium in Belgrade organized with Probiotic Excellence Center as partner. Five EAGEN presidents participated, presenting latest European guidelines for digestive disease treatment.
  • ACIESBiocoreTechnology or Integration · 1 January 2023Biotechnological company with which Probiotic Excellence Center researchers examined the resistance of Lactobacillus plantarum strains to acidic environment and stress caused by high pH values.
  • University of Belgrade Faculty of PharmacycoreStrategic or Co-development Partner · 1 January 2023AbelaPharm is a scientific-teaching base for pharmacy and technology students. PhD, specialist, and graduate theses have been developed at the Probiotic Excellence Center. Students present research at international congresses.
  • Medical Faculty KragujevaccoreStrategic or Co-development Partner · 1 January 2023Probiotic Excellence Center opened for pharmacy students from the Medical Faculty in Kragujevac, providing practical knowledge in probiotic production, research, and quality control. Partnership with Faculty Dean Prof. Dr Vladimir Jakovljević.
  • Savez medicinskih sestara predškolskih ustanova Srbije (Union of Medical Nurses of Preschool Institutions of Serbia)coreStrategic or Co-development Partner · 1 January 2023Collaboration on educational programs for parents and kindergarten staff on gut flora, immunity, and preventive health. Jointly published 'Guide for Preschool Age' and allergy guides through a 3-year educational workshop program.
  • Udruženje Treće doba (Third Age Association)minorGTM or Marketing Partner · 1 January 2023Partnership for World Osteoporosis Day event where AbelaPharm organized bone density screenings for elderly members of the association.
  • Pro-femina ConferenceminorGTM or Marketing Partner · 1 January 2023AbelaPharm participated in the 9th Pro-femina conference organized for World Menopause Day, with a panel on osteoporosis prevention.
  • Harvard Medical CommunityminorStrategic or Co-development Partner · 1 January 2023Probiotic Excellence Center references Harvard research on gut microbiota and leaky gut syndrome. Scientific director Dr. Krešimir Gjuračić maintains connections with leading international researchers in the probiotic field.
  • Medical Faculty NišminorStrategic or Co-development Partner · 1 January 2023Probiotic Excellence Center conducted the 'Probiotics from Industry to Digestive Tract' project at the Medical Faculty in Niš, enhancing knowledge and competencies of future professionals.
  • Fondacija Nataša KovačevićminorGTM or Marketing Partner · 1 January 2021Charitable partnership for the 'Take Health Into Your Own Hands, Let All Children Jump' campaign providing dynamic prosthetics for children. AbelaPharm donated 1,447,860 dinars — 1 RSD per box of BiVits ACTIVA sold between Dec 2021 and April 2022.
  • STADA Group (Germany)coreOthers · 1 January 2019AbelaPharm acquired a pharmaceutical manufacturing factory in Stari Banovci from German STADA Group in April 2019 for over 4 million euros. This represents a strategic acquisition enabling pharmaceutical drug manufacturing alongside dietary supplements.
  • Alvogen (USA)coreOthers · 1 January 2019AbelaPharm acquired a pharmaceutical manufacturing facility in Barice, near Vršac, from American company Alvogen. The modern GMP-certified facility was built in 2011 and provides capacity for 20 million pharmaceutical units per year.

Scale indicators18 records

Recent moves6 records

Expansion highlights6 records

Abela Pharm competitors and assessment

Company assessment

Broad incumbents

  • STADA Arzneimittel: German generics and consumer health company from which AbelaPharm acquired its Stari Banovci factory in 2019. Comparable as a European-focused generics and OTC manufacturer operating in the same regulatory and channel environment AbelaPharm is now targeting.
  • Chr. Hansen (Novonesis): Global bioscience company (now Novonesis post-merger with Novozymes) supplying probiotic strains, cultures, and enzymes to dietary supplement and dairy customers worldwide. Comparable as a science-backed probiotic supplier, though primarily B2B and far larger.
  • Alvogen: US-headquartered generics and pharmaceutical manufacturer whose Barice factory AbelaPharm acquired in 2019. Comparable as a generics and OTC player with European manufacturing footprint and a customer overlap with AbelaPharm's pharmaceutical ambitions.
  • Yakult Honsha: Global probiotic beverage and supplement giant with Lactobacillus casei strain products distributed in 40+ countries. Comparable as a category-defining incumbent in probiotics, though much larger and brand-led versus AbelaPharm's science-led pharmacy positioning.

Direct peers

  • BioGaia: Swedish probiotic R&D and marketing company specializing in Lactobacillus reuteri strains, sold globally through pharmacy and consumer health channels. Most directly comparable peer given probiotic focus, similar pharmacy-led distribution, and clinical evidence-driven positioning.
  • Winclove Probiotics: Dutch probiotic manufacturer focused on multi-strain and indication-specific formulations sold through pharmacies and healthcare professionals in Europe. Comparable in clinical evidence emphasis, pharmacy distribution, and indication-specific positioning (e.g., pediatric, GI).
  • Lallemand Health Solutions: Canadian probiotic manufacturer producing Saccharomyces boulardii (the same yeast that anchors AbelaPharm's flagship Bulardi product) and other microbial solutions for human health. Closest direct competitor in the S. boulardii space and a benchmark for probiotic contract manufacturing.
  • Probi AB: Swedish probiotic company developing and commercializing probiotic strains (including Lactobacillus plantarum 299v, the same strain used in AbelaPharm's Flobian). Direct competitor in documented probiotic strains and B2B/B2C probiotic commercialization.

Peers

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Abela Pharm social profiles

Digital presence

Abela Pharm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Abela Pharm leadership team

Management profile

Number of profiles

Profiles3 records

Abela Pharm subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Abela Pharm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Abela Pharm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abela Pharm

What does Abela Pharm do?

AbelaPharm develops, manufactures, and markets natural dietary supplements, probiotics, vitamins, herbal preparations, medical devices, and pharmaceutical drugs across 11 therapeutic categories. The company operates three GMP-certified production facilities in Serbia and sells its branded products through pharmacy chains domestically and through local distributors in 19+ export countries reaching more than 400 million consumers.

Is Abela Pharm a public or private company?

Abela Pharm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Abela Pharm founded?

Abela Pharm was founded in 2001. It employs 51 to 100 people.

Where is Abela Pharm based?

Abela Pharm is headquartered in Belgrade.

How does Abela Pharm make money?

Three revenue lines are on record. Dietary Supplements are the primary driver. The others are pharmaceutical Products and medical Devices.

Who are Abela Pharm's main competitors?

Broad incumbents on record are STADA Arzneimittel, Chr. Hansen (Novonesis), Alvogen and Yakult Honsha. Direct peers are BioGaia, Winclove Probiotics, Lallemand Health Solutions and Probi AB. Danone (Medical Nutrition) is listed as a peer.

Does Abela Pharm have an API?

No public API is recorded for Abela Pharm.

What industry is Abela Pharm in?

Abela Pharm's product category is Dietary Supplements and Pharmaceutical Manufacturing. Its primary akta.pro industry code is CRADAGAC, Multivitamins & Daily Packs, with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales